← Back to Influence Map
Entity DossierOrganization
GENENTECH
DC · US
Biotechnology company
Tracked direct giving
$0
LDA reported lobbying spend
$2,120,000
Connections
16
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
MMMMedicare/Medicaid
$3.4MHCRHealth Issues
$2.9MTAXTaxation/Internal Revenue Code
$1.4MCPTCopyright/Patent/Trademark
$760KBUDBudget/Appropriations
$760KMANManufacturing
$700KPHAPharmacy
$60KTRDTrade
$60KLobbying Firms Retained
CAPITOL COUNSEL LLC$720K
FORBES-TATE$700K
FARRAGUT PARTNERS LLP$700K
THE MCMANUS GROUP$700K
RIVENDELL GROUP LLP$510K
TIBER CREEK HEALTH STRATEGIES, INC.$120K
TARPLIN, DOWNS & YOUNG, LLC$60K
MARSHALL & POPP, LLC$60K
Bills Referenced in Lobbying Filings
PBM
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Retained | TIBER CREEK HEALTH STRATEGIES, INC. | Hired TIBER CREEK HEALTH STRATEGIES, INC. to lobby on Pharmaceuticals | Source |
| Retained | TARPLIN, DOWNS & YOUNG, LLC | Hired TARPLIN, DOWNS & YOUNG, LLC to lobby on Pharmaceuticals | Source |
| Retained | MARSHALL & POPP, LLC | Hired MARSHALL & POPP, LLC to lobby on Pharmaceuticals | Source |
| Commented on | Centers for Medicare & Medicaid Services | Public comment on CMS-2023-0127: Request for Information: Episode-based Payment Model | Source |
| Retained | OGR | Hired OGR to lobby on Pharmaceuticals | Source |
| Lobbied on | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $70,000 | Source |
| Subsidiary of | LISA BLUNT ROCHESTER FOR SENATE | Genentech is a subsidiary of Roche Group | Source |
| Subsidiary of | American Fuel And Petrochemical Manufacturers | Genentech is a subsidiary of Roche Group | Source |
| Subsidiary of | AMERICAN FUEL AND PETROCHEMICAL MANUFACTURERS (AFPM) | Genentech is a subsidiary of Roche Group | Source |
| Subsidiary of | Christopher Brochert | Genentech is a subsidiary of Roche Group | Source |
| Retained | FORBES-TATE | Hired FORBES-TATE to lobby on Pharmaceuticals | Source |
| Retained | RIVENDELL GROUP LLP | Hired RIVENDELL GROUP LLP to lobby on Pharmaceuticals | Source |
| Subsidiary of | F. Hoffman-La Roche Ltd | Genentech is a subsidiary of Roche Group | Source |
| Retained | CAPITOL COUNSEL LLC | Hired CAPITOL COUNSEL LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | FARRAGUT PARTNERS LLP | Hired FARRAGUT PARTNERS LLP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | THE MCMANUS GROUP | Hired THE MCMANUS GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |